Literature DB >> 1835387

ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells.

K Yagi1, M Shinbo, M Hashizume, L S Shimba, S Kurimura, Y Miura.   

Abstract

An ATP diphosphohydrolase (EC 3.6.1.5) is an enzyme hydrolyzing pyrophosphate bonds in nucleoside di- and triphosphates with broad substrate specificity in the presence of divalent cations. The ATPase and ADPase activities in the enzyme purified to homogeneity from bovine aortic vessel wall were insensitive to oligomycin, ouabain, and various protease treatments, and sensitive to azide and Ap5A. Bovine aorta endothelial and smooth muscle cells were cultured separately to characterize the ectonucleotidase activities. The activities were dependent on the addition of divalent cations and had broad substrate specificity. The ecto-ATPase and -ADPase activities were insensitive to oligomycin, ouabain, and protease treatments, and sensitive to azide and Ap5A. No enzyme degrading only ADP was found in the aortic vessel wall. Moreover, antiserum raised against purified ATP diphosphohydrolase inhibited the ecto-ATPase and -ADPase activities. These results indicated that ecto-ATPase and ecto-ADPase are not separate enzymes but are expressed by one enzyme, ATP diphosphohydrolase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835387     DOI: 10.1016/s0006-291x(05)81323-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  T-tubule membranes from chicken skeletal muscle possess an enzymic cascade for degradation of extracellular ATP.

Authors:  J Delgado; G Moro; A Saborido; A Megías
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  Kinetics of extracellular ATP hydrolysis by microvascular endothelial cells from rat heart.

Authors:  P Meghji; J D Pearson; L L Slakey
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

Review 3.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

4.  Involvement of Rho-kinase and tyrosine kinase in hypotonic stress-induced ATP release in bovine aortic endothelial cells.

Authors:  T Koyama; M Oike; Y Ito
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

5.  Characterization and localization of an ATP diphosphohydrolase activity (EC 3.6.1.5) in sarcolemmal membrane from rat heart.

Authors:  E Menezes de Oliveira; A M Oliveira Battastini; M N Meirelles; C Menezes Moreira; R Dutra Dias; J J Freitas Sarkis
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

Review 6.  Mechanisms of ATP release and signalling in the blood vessel wall.

Authors:  Alexander W Lohman; Marie Billaud; Brant E Isakson
Journal:  Cardiovasc Res       Date:  2012-06-07       Impact factor: 10.787

7.  ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model.

Authors:  D D Verma; T S Levchenko; E A Bernstein; V P Torchilin
Journal:  J Control Release       Date:  2005-10-17       Impact factor: 9.776

8.  Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets.

Authors:  S S Frassetto; R D Dias; J J Sarkis
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

9.  Purification of pancreas type-I ATP diphosphohydrolase and identification by affinity labelling with the 5'-p-fluorosulphonylbenzoyladenosine ATP analogue.

Authors:  J Sévigny; Y P Côté; A R Beaudoin
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

Review 10.  Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.

Authors:  J Matthew Rhett; Stephen A Fann; Michael J Yost
Journal:  Tissue Eng Part B Rev       Date:  2014-01-16       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.